The Teratogenicity of Anticonvulsant Drugs
Top Cited Papers
- 12 April 2001
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (15) , 1132-1138
- https://doi.org/10.1056/nejm200104123441504
Abstract
The frequency of major malformations, growth retardation, and hypoplasia of the midface and fingers, known as anticonvulsant embryopathy, is increased in infants exposed to anticonvulsant drugs in utero. However, whether the abnormalities are caused by the maternal epilepsy itself or by exposure to anticonvulsant drugs is not known.Keywords
This publication has 35 references indexed in Scilit:
- Anticonvulsant teratogenesis: I. A study design for newborn infantsTeratology, 1994
- Pattern of Malformations in the Children of Women Treated with Carbamazepine during PregnancyNew England Journal of Medicine, 1989
- Minor anomalies in offspring of epileptic mothersThe Journal of Pediatrics, 1988
- Seizure Disorders and PregnancyNew England Journal of Medicine, 1985
- Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine)Epilepsia, 1984
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- GROWTH RETARDATION, DYSMORPHIC FACIES AND MINOR MALFORMATIONS FOLLOWING MASSIVE EXPOSURE TO PHENOBARBITONE IN UTEROActa Paediatrica, 1976
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- Infants Exposed in Utero to Antiepileptic DrugsAmerican Journal of Diseases of Children, 1974
- MATERNAL EPILEPSY AND ABNORMALITIES OF THE FETUS AND NEWBORNThe Lancet, 1972